Look for the Return of Droperidol

October 2020

Droperidol will make its way BACK into many hospitals.

For decades, this injectable med was widely used to treat nausea and vomiting...headache...and agitation.

But it fell out of favor after FDA added a boxed warning about risks for QT prolongation and deadly heart arrhythmias in 2001.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Understand the New Format for Drug Expiration Dates
Acute Care Look for the Return of Droperidol
Practice Career Ladders Can Help You Move Up to Advanced Roles
Infection Control Know When You Need a COVID-19 Test
New Drugs Ensure a Smooth Transition to the New Trace Element Product
Immunizations Anticipate Confusion About Vaccines During COVID-19
Supplements Stay Alert for Patients Taking Risky Supplements Promoted for COVID-19
Infectious Diseases Keep COVID-19 Treatments in Perspective
Influenza Prevent Issues With Antiviral Meds for Flu